Manipal Health Enterprises IPO Day 2: GMP holds at 2%, Subscription reaches 15%. Should you Subscribe or Skip?

Manipal Health Enterprises’ large IPO is experiencing cautious investor interest on its second day. The grey market premium remains modest, indicating a subdued market sentiment. The company plans to use significant funds for debt repayment and strategic acquisitions. Brokerages largely view Manipal Health’s long-term prospects positively, despite premium valuations. The IPO’s share allotment is expected in early August 2026.

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.

Read more at the source

Leave a Reply

Your email address will not be published. Required fields are marked *